Mars unveils Valentine’s Day offerings
Last year, candy was the most popular gift given during the Valentine’s Day season.
Supplier News
Kroger’s Our Brands VP Juan De Paoli to speak at PLMA Conference
NEW YORK – PLMA announced Thursday that Juan De Paoli, vice president of Our Brands at the Kroger Co., will take the stage at its annual Meeting & Leadership Conference, March 22-24 in Orlando at the Hyatt Regency Grand Cypress. De Paoli will speak at a breakfast session on Friday, March 24.
CRN commemorates 50th anniversary in 2023
The Council for Responsible Nutrition (CRN), the leading trade association of the dietary supplement and functional food industry, celebrates its 50thanniversary in 2023.
Kadenwood announces the acquisition of Probulin
NEWPORT BEACH, Calif. – Kadenwood announced Wednesday the acquisition of Probulin, a globally renowned probiotic and microbiome health brand.
McKesson funds 60 scholarships for pharmacy technicians
While the pandemic exposed many health equity and public health needs in local communities, it also emphasized pharmacies as the most accessible and trusted health care destinations.
Axys brings modern, cloud-based technology to long-term care pharmacy
RedSail Technologies is proud to release a game-changer in the long-term care pharmacy industry. Axys, a cloud-based pharmacy management system, offers the industry a fresh and modern solution utilizing the latest technology available.
Henkel signs agreement with Shell on renewable-based ingredients
ROCKY HILL, Conn. – Henkel and Shell Chemical LP have agreed to a five-year collaboration to replace up to 200,000 tonnes of fossil feedstocks used in the manufacture of surfactants with feedstocks that are based on renewable raw materials.
SmartRx launches prescription discount card
LOS ANGELES – Higher prices across most health related goods and services have consumers reeling to find better options to save money. Starting today, these consumers have access to SmartRx, the newest prescription discount card.
RxPreferred Benefits and Mark Cuban Cost Plus Drugs team
RxPreferred Benefits, a transparent Pharmacy Benefit Administrator, and Mark Cuban Cost Plus Drugs, PBC (Cost Plus Drugs), have announced a new partnership today, focused on improving healthcare access and lowering drug spend.
Camber Pharmaceuticals launches generic Cambia
Camber Pharmaceuticals is pleased to announce the addition of Diclofenac Potassium for Oral Solution to its current portfolio.
Mielle Organics joins P&G Beauty in a major move for black entrepreneurs serving black women
P&G Beauty and Mielle Organics, a popular textured hair care brand rooted in natural ingredients, announced Wednesday that it will join P&G Beauty, pending regulatory approval, further expanding access to healthy hair products and services for Black women around the world.
Aurobindo Receives FDA Approval for Emzahh (Norethindrone Tablets USP)
EAST WINDSOR, N.J. – Aurobindo Pharma Limited has received final approval from U.S. Food and Drug Administration for its Abbreviated New Drug Application Emzahh (Norethindrone Tablets USP), 0.35mg.
Soleo Health named sole specialty pharmacy distributor of newly FDA-approved drug for Alzheimer’s
Soleo Health, an innovative leader and national provider of complex specialty pharmacy services, announced today it has been selected by Eisai Inc., a developer of pharmaceuticals, as the sole specialty pharmacy distribution partner for newly U.S.
Ozanian named chief experience officer at JUICE Pharma
Industry veteran Chris Ozanian has been appointed chief experience officer at creative and marketing communications agency JUICE Pharma Worldwide.
ProBioGen collaborates with Boehringer Ingelheim
ProBioGen announced on Tuesday a new non-exclusive collaboration with Boehringer Ingelheim on ProBioGen’s DirectedLuck transposase technology.
FDA grants accelerated approval for Alzheimer’s Disease Treatment
The U.S. Food and Drug Administration approved Leqembi (lecanemab-irmb) via the accelerated approval pathway for the treatment of Alzheimer’s disease. Leqembi is the second of a new category of medications approved for Alzheimer’s disease that target the fundamental pathophysiology of the disease.